...
首页> 外文期刊>Applied radiation and isotopes: including data, instrumentation and methods for use in agriculture, industry and medicine >Optimisation study of alpha-cyclotron production of At-211/Po-211g for high-LET metabolic radiotherapy purposes.
【24h】

Optimisation study of alpha-cyclotron production of At-211/Po-211g for high-LET metabolic radiotherapy purposes.

机译:用于高LET代谢放射治疗的At-211 / Po-211gα-回旋加速器生产的优化研究。

获取原文
获取原文并翻译 | 示例
           

摘要

The production of no-carrier-added (NCA) alpha-emitter (211)At/(211g)Po radionuclides for high-LET targeted radiotherapy and immunoradiotherapy, through the (209)Bi(alpha,2n) reaction, together with the required wet radiochemistry and radioanalytical quality controls carried out at LASA is described, through dedicated irradiation experiments at the MC-40 cyclotron of JRC-Ispra. The amount of both the gamma-emitter (210)At and its long half-lived alpha-emitting daughter (210)Po is optimised and minimised by appropriate choice of energy and energy loss of alpha particle beam. The measured excitation functions for production of the main radioisotopic impurity (210)At-->(210)Po are compared with theoretical predictions from model calculations performed at ENEA.
机译:通过(209)Bi(alpha,2n)反应以及所需的制备无载体的(NCA)α-发射体(211)At /(211g)Po放射性核素,用于高LET靶向放射治疗和免疫放射治疗通过在JRC-Ispra的MC-40回旋加速器上进行专门的辐射实验,描述了在LASA进行的湿法放射化学和放射分析质量控制。通过适当地选择能量和α粒子束的能量损失,可以优化和最小化伽玛发射体(210)At及其长半衰期的发射α的子体(210)Po的数量。将产生的主要放射性同位素杂质(210)At->(210)Po的测量激发函数与ENEA进行的模型计算得出的理论预测进行了比较。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号